Related Experiment Video
Updated: Mar 17, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Federico Pietrocola1, Jonathan Pol2, Erika Vacchelli1
1Gustave Roussy Cancer Campus, 94800 Villejuif, France; INSERM, U1138, 75006 Paris, France; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France.
Caloric restriction mimetics (CRMs) enhance chemotherapy by triggering autophagy, depleting regulatory T cells, and boosting anti-cancer immunity in mice. This improves tumor immunosurveillance and reduces tumor mass.
Area of Science:
- Oncology
- Immunology
- Cellular Biology
Background:
- Caloric restriction mimetics (CRMs) mimic nutrient deprivation by reducing lysine acetylation and inducing autophagy.
- Autophagy plays a role in regulating cellular processes and immune responses.
- Regulatory T cells (Tregs) can suppress anti-cancer immunity.
Purpose of the Study:
- To investigate the effect of CRMs on autophagy-competent and deficient KRAS-induced lung cancers.
- To determine if CRMs can enhance the efficacy of chemotherapy.
- To explore the role of Tregs in CRM-mediated anti-cancer effects.
Main Methods:
- Treatment of mice with mutant KRAS-induced lung cancers with hydroxycitrate, a CRM.
- Assessment of Treg populations in tumors.
- Evaluation of tumor growth inhibition by chemotherapy in conjunction with CRMs or short-term fasting.
- Analysis of tumor-infiltrating lymphocytes.
Main Results:
- Hydroxycitrate depleted Tregs from autophagy-competent, but not autophagy-deficient, KRAS-induced lung cancers, improving immunosurveillance and reducing tumor mass.
- Short-term fasting and unrelated CRMs (hydroxycitrate, spermidine) enhanced chemotherapy's tumor growth inhibition in autophagy-competent tumors.
- These effects were dependent on T lymphocytes and accompanied by Treg depletion from the tumor bed.
Conclusions:
- CRMs can enhance anti-cancer therapy by modulating the tumor microenvironment through autophagy.
- Targeting autophagy with CRMs may be a viable strategy to improve cancer immunotherapy and chemotherapy outcomes.
- The depletion of Tregs is a key mechanism by which CRMs exert their anti-cancer effects.
More Related Videos
07:36Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies